Jen L, PhD
LightNews LightNews
banner
drjkyl.bsky.social
Jen L, PhD
@drjkyl.bsky.social
2.9K followers 16K following 320 posts
Executive Editor/Team Lead Open Access Science & Medicine Journals Sage Publishing
Opinions = mine

http://linkedin.com/in/jlovick-editor

#oncology #cancerresearch #medicine #biology #cardiology #neurology #microbiology #publichealth #healthcare
Posts Replies Media Videos
Pinned
drjkyl.bsky.social
Jen L, PhD @drjkyl.bsky.social · Feb 21
Introduction - PhD working in academic publishing, lead a team of amazing Managing Editors that support @sagepub.com @journals.sagepub.com 's Open Access Biomedical Journals. I'll be sharing recent articles from our journals that I find interesting. Happy to connect with researchers! 📖🔬🧪💊⚕️
drjkyl.bsky.social
From Simple Scores to Intelligent Systems: Encouraging the Development, Validation and Adoption of Robust Prognostic Tools in Small Cell Lung Cancer
@tcrtcancer.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#SCLC #biomarker #deeplearning #oncology #cancer #openaccess
February 6, 2026 at 11:22 PM
drjkyl.bsky.social
Ga-68-Edotreotide PET/CT SSTR Total Tumor Volume as a Predictor of Outcome in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors
@cancer-control.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#NETs #medicalimaging #cancertreatment #oncology #openaccess
February 6, 2026 at 11:19 PM
drjkyl.bsky.social
A preliminary preclinical assessment of macromolecular crowding in tissue engineering

Science Progress
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#celltransplantation #stromalcells #bioengineering #medicine #openaccess
February 6, 2026 at 11:16 PM
drjkyl.bsky.social
Efgartigimod as a treatment for people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a plain language summary of publication of the ADHERE trial
@taneuroldisord.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#qualityoflife #PLSP #clinicaltrial
February 6, 2026 at 11:13 PM
drjkyl.bsky.social
Skin cancer awareness and sun protection advice for outdoor workers in Australia: Review of communication channels to optimise reach and relevance

Digital Health
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#healthcommunication #technology #publichealth #openaccess
February 6, 2026 at 11:11 PM
drjkyl.bsky.social
Biomarker analysis of circulating tumor DNA in clinical stage III melanoma patients treated with neoadjuvant immunotherapy combined with targeted therapy
@tamedoncol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#skincancer #PET #targetedtherapy #oncology #openaccess
February 6, 2026 at 11:09 PM
drjkyl.bsky.social
Incidence of urinary infections and urosepsis after ureteroscopy for stone disease: a systematic review of literature

Therapeutic Advances in Urology
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#UTIs #uretericstone #kidneystone #treatment #medicine #openaccess
February 6, 2026 at 11:07 PM
drjkyl.bsky.social
Vedolizumab in inflammatory bowel disease: pharmacokinetics and the role of immunomodulator co-therapy
@tagastroenterol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#gastroenterology #crohns #ulcerativecolitis #medicine #treatment #openaccess
February 6, 2026 at 11:04 PM
drjkyl.bsky.social
Prospective Breast Cancer Biomarkers Identified Using miR-526b-Driven Metabolic Alterations
@cancerinformatics.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#cancerresearch #metabolism #diagnostics #openaccess
February 6, 2026 at 10:54 PM
Reposted by Jen L, PhD
taneuroldisord.bsky.social
New international Delphi consensus clarifies best practices for steroid use in generalized #MyastheniaGravis:

Key takeaways:
👉Aim ≤5 mg/day long‑term
👉Prioritize biologics to reduce OCS burden
👉Individualize tapering strategies
journals.sagepub.com/doi/full/10....
February 5, 2026 at 10:00 AM
Reposted by Jen L, PhD
naturalproductcomm.bsky.social
Top Read Papers on Natural Product Communications - February 2026

💡1. Mechanistic Insights into the Pharmacological Actions of Flavonoids: A Comprehensive Review

journals.sagepub.com/doi/10.1177/...
February 5, 2026 at 10:13 AM
Reposted by Jen L, PhD
tamedoncol.bsky.social
Review: Histologic transformation is a key mechanism of resistance in driver‑positive NSCLC, leading to aggressive SCLC, squamous, or neuroendocrine phenotypes.⬇️ summarize mechanisms and treatment options.
🔗 buff.ly/jJq7xOQ
#NSCLC #LungCancer #Oncology #TargetedTherapy
February 4, 2026 at 6:04 PM
Reposted by Jen L, PhD
taneuroldisord.bsky.social
Important German consensus paper on vaccination strategies in people with autoimmune neurological disorders:

Recommendations are provided on types and timing of vaccinations and ways to optimize immunization in people on different immunotherapies.
journals.sagepub.com/doi/full/10....
February 3, 2026 at 10:29 AM
Reposted by Jen L, PhD
linglingtian.bsky.social
A nationwide analysis from Japan (n=741) reveals that 38% of patients with LA-NSCLC meet criteria for vulnerability—and this group shows markedly shorter OS after CCRT. Cachexia emerges as the strongest predictor of poor outcomes.
🔗 buff.ly/FjQd1Zu
February 4, 2026 at 10:31 AM
Reposted by Jen L, PhD
taneuroldisord.bsky.social
Rethinking the gut-brain axis in #MultipleSclerosis:
👉 Short-chain fatty acid decline could reflect disease progression, not the initial demyelinating event
🔎Data needed to track microbiome changes across MS trajectories and under different immunotherapies
journals.sagepub.com/doi/full/10....
February 4, 2026 at 11:11 AM
drjkyl.bsky.social
📣Overview of Molecular Imaging Methods in Early Skin Cancer Detection Highlights Benefits of the Orlucent® Skin Fluorescent Imaging System -

New review in @tcrtcancer.bsky.social
@apploniarose.bsky.social @journals.sagepub.com

#cancerresearch #oncology #melanoma #cancerdetection #openaccess
Overview of Molecular Imaging Methods in Early Skin Cancer Detection Highlights Benefits of the Orlucent® Skin Fluorescent Imaging System - Orlucent
LOS GATOS, Calif., January 22, 2026 – A review article in Technology in Cancer Research and Treatment discusses the uses, advantages and limitations of molecular imaging methods employed in the detect...
orlucent.com
February 3, 2026 at 8:11 PM
Reposted by Jen L, PhD
tamedoncol.bsky.social
A Phase IV real‑world analysis examined fruquintinib safety in two under‑studied CRC populations in China: young adults (<50) and the late‑elderly (≥75). Safety events were comparable between age groups, supporting broad applicability.
buff.ly/1Wpdefh
#ColorectalCancer
February 2, 2026 at 2:18 AM
Reposted by Jen L, PhD
tainfdis.bsky.social
Peptide-based vaccines are redefining precision immunology, offering safety, specificity,scalable manufacturing. This review explores how bioinformatics-driven epitope design, nanoparticles,& next-gen adjuvants are fighting viral threats 🚀🦠
journals.sagepub.com/doi/full/10....
February 2, 2026 at 1:16 PM
Reposted by Jen L, PhD
taneuroldisord.bsky.social
New important data for managing rare post-transplant neuropathies in TAND:
Patisiran shows promise for acquired amyloid polyneuropathy in domino liver transplant recipients—improved NIS scores over 22 months with no major renal, cardiac, or immunologic adverse effects.
🔗 doi.org/10.1177/1756...
February 2, 2026 at 5:39 PM
Reposted by Jen L, PhD
tainfdis.bsky.social
Ticks strike twice 🐜🐜 Fatal Babesia microti/Borrelia burgdorferi coinfection presenting as acute liver failure and shock. Read full case @
journals.sagepub.com/doi/full/10....
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
journals.sagepub.com
January 25, 2026 at 2:04 PM
Reposted by Jen L, PhD
linglingtian.bsky.social
Belzutifan has demonstrated clinical activity across treatment lines in clear cell RCC.
Evidence supports its use as both front‑ and later‑line therapy, including in combination with TKIs.
🔗 Full article: buff.ly/joEgxsx
#RCC #KidneyCancer #Belzutifan
January 27, 2026 at 8:15 AM
Reposted by Jen L, PhD
taneuroldisord.bsky.social
Do patients with AQP4-IgG+ #NMOSD have specific volumetric brain and spinal cord changes that could inform MRI-guided disease monitoring?

@josephineheine.bsky.social and colleagues conducted a Systematic Review & Meta-Analysis to find out:
journals.sagepub.com/doi/full/10....
January 27, 2026 at 11:19 AM
Reposted by Jen L, PhD
taneuroldisord.bsky.social
We're proud to support and publish #AccessibleResearch!

This Plain Language Summary of a Publication (#PLSP) covers the ADHERE clinical study on #efgartigimod in CIDP in an accessible form.
We hope you enjoy the informative, easy-to-understand infographics: journals.sagepub.com/doi/epdf/10....
January 27, 2026 at 3:00 PM
Reposted by Jen L, PhD
celltransplant1992.bsky.social
3D bioprinting and mesenchymal stem cells: A bibliometric analysis of emerging trends and advancements
doi.org/10.1177/0963...
#3DPrinting #MSC
@journals.sagepub.com
January 28, 2026 at 8:00 AM
Reposted by Jen L, PhD
celltransplant1992.bsky.social
Impact of Kellgren–Lawrence grade on clinical outcomes following adipose-derived stem cell therapy for #knee #osteoarthritis: A propensity score–matched retrospective cohort study
doi.org/10.1177/0963...
#stemcell
@journals.sagepub.com
January 28, 2026 at 8:23 AM